Reversibility of liver fibrosis

Journal Title: Annals of Hepatology - Year 2009, Vol 8, Issue 4

Abstract

Liver cirrhosis is a major cause of morbidity and mortality worldwide and has very limited therapeutic options. Regardless of the aetiology, hepatic fibrosis is a characteristic feature of chronic liver disease. Our knowledge regarding the pathogenesis of this scarring has grown exponentially in the past 25 years. It has now clear that this is a highly dynamic process and the long-held dogma that it is irreversible and relentlessly progressive is now being challenged. In this review, we will summarise the key pathogenic mechanisms at play and will focus on the evidence demonstrating that liver fibrosis is reversible in humans and animal models. In particular, we will examine the role of hepatic stellate cells, MMPs, TIMPs and macrophages in this process. Finally, we will discuss some of the studies aimed to therapeutically target the resolution of fibrosis and their potential for translation into a badly-needed treatment modality in the clinical setting.

Authors and Affiliations

Prakash Ramachandran, John Iredale

Keywords

Related Articles

Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood

Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive or sporadic disorder, characterized by recurrent episodes of intense pruritus and jaundice that resolve spontaneously without leaving conside...

Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction

Background and aims. Cytokeratin19 positive (CK19+) hepatocellular carcinoma (HCC) is thought to derive from liver progenitor cells (LPC). However, whether peritumoralductular reaction (DR) differs between CK19+ and CK1...

The prevalence of nonalcoholic fatty liver disease in the Americas

Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of the main causes of chronic liver disease worldwide and is directly linked to the increased prevalence of obesity and ty...

Download PDF file
  • EP ID EP77882
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

Prakash Ramachandran, John Iredale (2009). Reversibility of liver fibrosis. Annals of Hepatology, 8(4), 283-291. https://europub.co.uk/articles/-A-77882